Based on the findings of our in vivo experiment, we have successfully illustrated that the suppression of RIPK2 effectively impedes the proliferation of tumor cells in vivo through its influence on the cell cycle-associated protein PCNA and apoptosis. The gene discussed is PCNA; the disease is neoplasm.